piracetam has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " focuses on the current clinical development of the antiepileptic drug levetiracetam for amyotrophic lateral sclerosis." | 7.73 | Clinical development of levetiracetam for amyotrophic lateral sclerosis. ( Davies, SL; Moral, MA, 2006) |
| " focuses on the current clinical development of the antiepileptic drug levetiracetam for amyotrophic lateral sclerosis." | 3.73 | Clinical development of levetiracetam for amyotrophic lateral sclerosis. ( Davies, SL; Moral, MA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, SL | 1 |
| Moral, MA | 1 |
1 other study available for piracetam and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Clinical development of levetiracetam for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anticonvulsants; Clinical Trials as Topic; Humans; Levetirac | 2006 |